Jonathan M. Flanagan
Baylor College of Medicine(US)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders, Blood groups and transfusion, Prenatal Screening and Diagnostics, Erythrocyte Function and Pathophysiology
Most-Cited Works
- → Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia(2011)166 cited
- → Characterization of Cytoplasmic Caspase-2 Activation by Induced Proximity(2009)152 cited
- → Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes(2013)88 cited
- → Organ-on-chips made of blood: endothelial progenitor cells from blood reconstitute vascular thromboinflammation in vessel-chips(2019)87 cited
- → Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia(2017)79 cited
- → Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia(2013)66 cited
- → Pain and other non‐neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial(2013)48 cited
- → Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: Results from the BABY‐HUG phase III clinical trial(2011)44 cited
- → Whole Exome Sequencing Identifies Novel Genes for Fetal Hemoglobin Response to Hydroxyurea in Children with Sickle Cell Anemia(2014)38 cited
- → Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia(2016)36 cited